Portfolio Companies 2026 for Newpath Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Newpath Partners accounts for 8 tracked companies with verified cap-table data, 8 of which disclose round sizes totalling $1.3B. The median disclosed raise is $103M, and the largest is Neumora Therapeutics at $500M, ahead of Orbital Therapeutics ($270M) and Myeloid Therapeutics ($195M).
The names that recur most often on these portfolio cap tables are Newpath Partners (8 companies), ARCH Venture Partners (5 companies), Alexandria Venture Investments (3 companies), F-Prime Capital (3 companies), Mubadala Capital (2 companies), Polaris Partners (2 companies). By latest disclosed round, the market skews Series A (5), Series B (2), Seed (1).
Newpath Partners GP III, L.P. profile · All research reports